Pilot Study of Crenolanib Combined With Standard Salvage Chmetherapy in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Crenolanib (Primary) ; Cytarabine; Etoposide; Fludarabine; Idarubicin; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Sponsors AROG Pharmaceuticals
- 23 Jan 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 23 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 06 Dec 2016 Interim results (n=13) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology